Trebgast, Germany

Anja Trager


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anja Trager: Pioneering Innovations in Nanostructured Delivery Systems

Introduction

Anja Trager, a forward-thinking inventor based in Trebgast, Germany, has made significant strides in the field of pharmaceutical delivery systems. With a focus on improving treatment efficacy, Trager has developed innovative technologies aimed at enhancing the precision of drug delivery to target tissues.

Latest Patents

Trager holds one notable patent titled "Cell-specific targeting using nanostructured delivery systems." This invention revolves around a specialized delivery system that integrates polymers and lipids with polymethine dyes. These dyes serve as targeting units, facilitating the directed transport of the delivery system into specified tissues. The patent also encompasses pharmaceutical compositions and outlines the utility of her innovative system for administering pharmaceutical active ingredients, particularly aimed at treating liver and kidney diseases.

Career Highlights

Anja Trager has contributed to advancements in drug delivery mechanisms through her pioneering ideas and inventions. Her work not only emphasizes the importance of nanotechnology in modern medicine but also showcases her commitment to addressing complex health issues through innovative solutions.

Collaborations

Trager collaborates with esteemed colleagues such as Michael Bauer and Ulrich Sigmar Schubert at Smartdelivery GmbH. These associations foster an environment of innovation and creativity, driving progress in the field of drug delivery systems and enhancing the potential impact of her inventions.

Conclusion

Anja Trager stands out as a remarkable inventor whose work in nanostructured delivery systems exemplifies the intersection of technology and healthcare. Her patent reflects a critical advancement in targeted therapy, potentially transforming how liver and kidney diseases are treated. Through her collaborations and ongoing endeavors, Trager continues to inspire innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…